a drug company
Industry Biotechnology
A.I.dvisor tells us that CRIS and INKT have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CRIS and INKT's prices will move in lockstep.
Ticker / NAME | Correlation To CRIS | 1D Price Change % | ||
---|---|---|---|---|
CRIS | 100% | +1.27% | ||
INKT - CRIS | 28% Poorly correlated | -5.59% | ||
XENE - CRIS | 28% Poorly correlated | -0.52% | ||
GSGTF - CRIS | 25% Poorly correlated | N/A | ||
ZYME - CRIS | 25% Poorly correlated | -5.52% | ||
GLMD - CRIS | 25% Poorly correlated | +3.68% | ||
More |
Ticker / NAME | Correlation To CRIS | 1D Price Change % |
---|---|---|
CRIS | 100% | +1.27% |
drugs theme (254 stocks) | 20% Poorly correlated | -1.67% |
biotechnology theme (238 stocks) | 11% Poorly correlated | -1.76% |